| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6830004 | Seizure | 2018 | 7 Pages |
Abstract
Current evidence shows lacosamide as a good option in pediatric patients with focal drug-resistant epilepsy and refractory status epilepticus as an add-on therapy given its efficacy on seizure control and safety profile. The use of lacosamide in Lennox-Gastaut syndrome shows conflicting data. Large randomized controlled studies in the pediatric population are necessary to substantiate these findings.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Johann Sebastián Ortiz de la Rosa, Lady Diana Ladino, Paula Juliana RodrÃguez, MarÃa Camila Rueda, Juan Pablo PolanÃa, Angie Catalina Castañeda,